The Relationships Between BNP and Neurocardiac Injury Severity,Noninvasive Cardiac Output,and Outcomes After Aneurysmal Subarachnoid Hemorrhage

Abstract

Introduction:

Neurocardiac injury, a type of myocardial dysfunction associated with neurological insult to the brain, occurs in 31–48% of aneurysmal subarachnoid hemorrhage (aSAH) patients. Cardiac troponin I (cTnI) is commonly used to diagnose neurocardiac injury. Brain natriuretic peptide (BNP), another cardiac marker, is more often used to evaluate degree of heart failure. The purpose of this study was to examine the relationships between BNP and (a) neurocardiac injury severity according to cTnI, (b) noninvasive continuous cardiac output (NCCO), and (c) outcomes in aSAH patients.

Method:

This descriptive longitudinal study enrolled 30 adult aSAH patients. Data collected included BNP and cTnI levels and NCCO parameters for 14 days and outcomes (modified Rankin Scale [mRS] and mortality) at discharge and 3 months. Generalized estimating equations were used to evaluate associations between BNP and cTnI, NCCO, and outcomes.

Results:

BNP was significantly associated with cTnI. For every 1 unit increase in log BNP, cTnI increased by 0.05 ng/ml (p = .001). Among NCCO parameters, BNP was significantly associated with thoracic fluid content (p = .0003). On multivariable analyses, significant associations were found between BNP and poor mRS. For every 1 unit increase in log BNP, patients were 3.16 times more likely to have a poor mRS at discharge (p = .021) and 5.40 times more likely at 3 months (p < .0001).

Conclusion:

There were significant relationships between BNP and cTnI and poor outcomes after aSAH. BNP may have utility as a marker of neurocardiac injury and outcomes after aSAH.

Keywords

brain natriuretic peptide cardiac troponin I aneurysmal subarachnoid hemorrhage neurocardiac injury noninvasive cardiac output

Get full access to this article

View all access options for this article.

References

Banki

N. M.

Kopelnik

Dae

M. W.

Miss

Tung

Lawton

M. T.

… Zaroff

J. G.

(2005). Acute neurocardiac injury after subarachnoid hemorrhage. Circulation, 112, 3314–3319.

Bhatia

Nayyar

Dhindsa

(2003). Brain natriuretic peptide in diagnosis and treatment of heart failure. Journal of Postgraduate Medicine, 49, 182–185.

Bonita

Beaglehole

(1988). Modification of Rankin scale: Recovery of motor function after stroke. Stroke, 19, 1497–1500.

Crago

E. A.

Kerr

M. E.

Kong

Baldiserri

Horowitz

Yonas

Kassam

(2004). The impact of cardiac complications on outcome in the SAH population. Acta Neurologica Scandinavica, 110, 248–253.

Cremers

C. H.

van der Bilt

I. A.

van der Schaaf

I. C.

Vergouwen

M. D.

Dankbaar

J. W.

Cramer

M. J.

… Rinkel

G. J.

(2016). Relationship between cardiac dysfunction and cerebral perfusion in patients with aneurysmal subarachnoid hemorrhage. Neurocritical Care, 24, 202–206.

Davis

Espiner

Richards

(1994). Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet, 343, 440–444.

Duello

K. M.

Nagel

J. P.

Thomas

C. S.

Blackshear

J. L.

Freeman

W. D.

(2015). Relationship of troponin T and age- and sex-adjusted BNP elevation following subarachnoid hemorrhage with 30-day mortality. Neurocritical Care, 23, 59–65.

Frangiskakis

J. M.

Hravnak

Crago

E. A.

Tanabe

Kip

K. E.

Gorcsan

… London

(2009). Ventricular arrhythmia risk after subarachnoid hemorrhage. Neurocritical Care, 10, 287–294.

Hravnak

Frangiskakis

J. M.

Crago

E. A.

Chang

Tanabe

Gorcsan

Horowitz

M. B.

(2009). Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage. Stroke, 40, 3478–3484.

10.

Hunt

W. E.

Hess

R. M.

(1968). Surgical risk as related to time of intervention in the repair of intracranial aneurysms. Neurosurgery, 28, 14–20.

11.

Kang

W. S.

Lee

J. H.

Shin

H. J.

Kim

S. H.

Kim

T. Y.

Seo

D. M.

Yoon

T. G.

(2012). Noninvasive cardiac output monitoring in paediatric cardiac surgery: Correlation between change in thoracic fluid content and change in patient body weight. Journal of International Medical Research, 40, 2295–2304.

12.

Kawamura

Inoue

Sakai

Nakashima

(2012). Brain natriuretic peptide in subarachnoid hemorrhage. Neurosurgery, 40, 1065–1070.

13.

Kilbourn

K. J.

Ching

Silverman

D. I.

McCullough

Brown

R. J.

(2015). Clinical outcomes after neurogenic stress induced cardiomyopathy in aneurysmal sub-arachnoid hemorrhage: A prospective cohort study. Clinical Neurology and Neurosurgery, 128, 4–9.

14.

Macmillan

C. S.

Grant

I. S.

Andrews

P. J.

(2002). Pulmonary and cardiac sequelae of subarachnoid hemorrhage: Time for active management. Intensive Care Medicine, 28, 1012–1023.

15.

McGirt

M. J.

Blessing

Nimjee

S. M.

Friedman

A. H.

Alexander

M. J.

Laskowitz

D. T.

Lynch

J. R.

(2004). Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery, 54, 1369–1373.

16.

Meaudre

Jego

Kenane

Montcriol

Boret

Goutorbe

… Palmier

(2009). B-type natriuretic peptide release and left ventricular filling pressure assessed by echocardiographic study after subarachnoid hemorrhage: A prospective study in non-cardiac patients. Critical Care, 13, 1–11.

17.

Miketic

J. K.

Hravnak

Sereika

S. M.

Crago

E. A.

(2010). Elevated cardiac troponin I and functional recovery and disability in patients after aneurysmal subarachnoid hemorrhage. American Journal of Critical Care, 19, 522–529.

18.

Naidech

A. M.

Kreiter

K. T.

Janjua

Ostapkovich

N. D.

Parra

Commichau

… Mayer

S. A.

(2005). Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation, 112, 2851–2856.

19.

Salem

Vallee

Depret

Callebert

Pierre

Maurice

… Mebazaa

(2014). Subarachnoid hemorrhage induces an early and reversible cardiac injury associated with catecholamine release: One-week follow-up study. Critical Care, 18, 558.

20.

Schillinger

(2005). Brain natriuretic peptide and early cardiac dysfunction after subarachnoid hemorrhage. Stroke, 36, 1570–1571.

21.

Sviri

G. E.

Shik

Raz

Soustiel

J. F.

(2003). Role of brain natriuretic peptide in cerebral vasospasm. Acta Neurochirurgica, 145, 851–860.

22.

Takahashi

Totsune

Sone

Ohneda

Murakami

Itoi

Mouri

(1992). Human brain natriuretic peptide-like immunoreactivity in human brain. Peptides, 13, 121–123.

23.

Taub

P. R.

Fields

J. D.

A. H.

Miss

J. C.

Lawton

M. T.

Smith

W. S.

… Ko

N. U.

(2011). Elevated BNP is associated with vasospasm-independent cerebral infarction following aneurysmal subarachnoid hemorrhage. Neurocritical Care, 15, 13–18.

24.

Tung

Kopelnik

Banki

Ong

Lawton

M. T.

… Zaroff

(2004). Predictors of neurocardiac injury after subarachnoid hemorrhage. Stroke, 35, 548–553.

25.

Tung

P. P.

Olmsted

Kopelnik

Banki

N. M.

Drew

B. J.

… Zaroff

J. G.

(2005). Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke, 36, 1567–1571.

26.

Vanderheyden

Goethals

Verstreken

De Bruyne

Muller

Van Schuerbeeck

Bartunek

(2004). Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. Cardiology, 44, 2350–2354.

27.

Wybraniec

Mizia-Stec

Krzych

(2014). Neurocardogenic injury in subarachnoid hemorrhage: A wide spectrum of catecholamine-mediated brain-heart interactions. Cardiology, 21, 220–228.

28.

Yarlagadda

Rajendran

Miss

J. C.

Banki

N. M.

Kopelnik

A. H.

… Zaroff

J. G.

(2006). Cardiovascular predictors of in-patient mortality after subarachnoid hemorrhage. Neurocritical Care, 5, 102–107.